Month: October 2020
-
Infographic – Q3 Health Care A.I. Funding Soars
In the third quarter of 2020, worldwide investments in artificial intelligence applications in health care rose to a new high, $2.1 billion.
-
Keeping Your Business Out of Deep Debt
It is possible to avoid getting into deep debt, by which we mean the situation where you are genuinely struggling.
-
Covid-19 Drug Biotech Raises $300M in IPO
A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock.
-
Will an R&D Department Help Your Small Business?
Any business can run a research and development team and it will help to push your company forward in a lot of different ways.
-
FDA to Use Lung Chip Model for Covid-19 Testing
The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes.
-
Are These Science Fiction Concepts In Our Future?
Let’s explore some of these possibilities in turn to answer this question.
-
Covid-19 Antibodies Cut Viral Load, Medical Visits
Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among non-hospitalized Covid-19 patients.
-
200M Covid-19 Vaccine Doses Donated to Int’l Effort
Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide.
-
Helping an Employee Back Into the Office
What does it take to get an employee back to work in difficult times but also after an employee’s individual difficult time?
-
Novartis Gains Synthetic Protein Therapies for Covid-19
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components.